相关实验视频
Updated: Sep 18, 2025

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.5K
肌痛性骨质疏松症的失脂症:一个系统的审查和元分析
Vasileios Giannopapas1, Vassiliki Smyrni1, Georgia Papagiannopoulou1
1Second Department of Neurology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Medicina (Kaunas, Lithuania)
|June 27, 2025
概括
大约四分之一的患有Myasthenia Gravis (MG) 的患者也患有脂质失调症 (DL). 随着MG发病的年龄,DL的患病率增加,这表明需要个性化患者管理策略.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 骨髓灰质炎 (MG) 是一种自身免疫性疾病,导致肌肉衰弱和疲劳.
- 伴随性疾病,如失脂症 (DL),可以加剧MG症状,降低生活质量.
研究的目的:
- 系统地审查和元分析被诊断为Myasthenia Gravis的患者中脱脂症的患病率.
- 与健康个体相比,评估Myasthenia Gravis和失脂症风险之间的关联.
主要方法:
- 一个系统的审查和元分析,遵循PRISMA指南.
- 在MEDLINE,Scopus和谷歌学者数据库中搜索相关研究.
- 分析了包括98,947名Myasthenia Gravis患者在内的19项研究.
主要成果:
- 在Myasthenia Gravis患者中,失脂症的综合患病率为23.64%.
- 与对照组相比,在MG患者中没有观察到显著增加血脂障碍的相对风险 (RR: 1.13).
- 脱脂症的患病率与MG发病年龄呈正相关性 (p < 0.001),每年增加2%.
结论:
- 大约有25%的Myasthenia Gravis患者出现并发性脂质失调症.
- 肌痛性骨质疏松症发病时的年龄是影响肌痛性骨质疏松症患病率的一个重要因素.
- 强调需要针对MG患者制定量身定制的治疗计划和评估,包括降脂疗法和Lp (a) 评估.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
884
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
884
Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Chemical Synapses
9.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K

